西陇科学(002584) - 2023 Q1 - 季度财报

Revenue and Profit - The company's revenue for Q1 2023 was ¥1,937,787,670.11, representing a 41.37% increase compared to ¥1,370,689,076.75 in the same period last year[5] - Net profit attributable to shareholders decreased by 87.27% to ¥10,032,938.44 from ¥78,789,802.66 year-on-year[5] - Basic and diluted earnings per share dropped by 84.62% to ¥0.02 from ¥0.13 in the same period last year[5] - The net profit for Q1 2023 was CNY 10,263,465.80, a significant decrease from CNY 78,992,204.84 in Q1 2022, representing a decline of approximately 87%[21] - The total comprehensive income for Q1 2023 was CNY 10,209,000.26, compared to CNY 78,972,725.68 in Q1 2022, indicating a decrease of approximately 87%[22] Cash Flow and Operating Activities - The net cash flow from operating activities was negative at -¥13,769,371.14, a decline of 208.42% compared to ¥12,699,955.54 in the previous year[11] - The cash flow from operating activities showed a net outflow of CNY 13,769,371.14, contrasting with a net inflow of CNY 12,699,955.54 in the same period last year[23] - The net cash flow from financing activities was -CNY 181,091,623.31, compared to -CNY 194,630,992.88 in the same period last year[23] Assets and Liabilities - Total assets increased by 1.61% to ¥5,057,362,009.89 from ¥4,977,416,163.23 at the end of the previous year[5] - The total liabilities increased to CNY 2,731,999,097.66 from CNY 2,661,074,952.66, indicating a rise of 2.6%[18] - The cash and cash equivalents at the end of the first quarter were CNY 746,942,400.01, up from CNY 691,010,308.36 at the beginning of the year, representing an increase of 8.1%[16] - The inventory balance increased to CNY 628,233,968.66 from CNY 508,198,483.15, marking a significant rise of 23.6%[16] - The company experienced a 35.08% decrease in trading financial assets, dropping to ¥194,525,348.36 from ¥299,652,718.51 due to bank wealth management products maturing[8] Costs and Expenses - The company reported a significant increase in main business costs, which rose by 46.57% to ¥1,821,756,346.94 due to higher demand for specialized chemical products[10] - The total operating costs for the first quarter of 2023 were CNY 1,921,849,607.63, up 42.4% from CNY 1,347,511,178.74 in the previous year[19] - The company incurred a total operating profit of CNY 10,843,265.98, a decrease from CNY 88,433,285.73 in the previous year[21] - The company’s research and development expenses for the first quarter were CNY 13,057,237.98, down 19.0% from CNY 16,110,350.98 in the previous year[19] Investment and Financing - Investment income plummeted by 101.31% to -¥951,681.56 from ¥72,607,438.26 in the previous year, primarily impacting net profit[10] - The total cash inflow from investment activities was CNY 300,346,508.14, down from CNY 389,951,398.69 in Q1 2022[23] - Short-term borrowings increased by 32.28% to ¥992,194,390.15 from ¥750,092,603.45, indicating a rise in financing needs[9] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 68,218, with no preferred shareholders[13] - The net profit attributable to the parent company for the first quarter of 2023 was not explicitly stated but can be inferred from the increase in revenue and costs[19]